We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Vacuum Assisted Wound Closure Therapy May Be Pointless

By HospiMedica International staff writers
Posted on 29 Jun 2011
Negative-pressure wound therapy (NPWT) probably does not promote wound healing after all, according to a new meta-analysis. More...


Researchers at the Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG; Cologne, Germany) conducted a systematic search of the PubMed and the Cochrane Library databases for randomized, controlled trials (RCTs) of NPWT for the treatment of acute or chronic wounds. The primary outcome was complete wound closure; secondary endpoints included adverse events such as death, secondary amputations, fistula formation, wound infection, time to complete wound closure, and reduction in wound size. In all, 21 reports met selection criteria.

Of these studies, 9 RCTs were new, in addition to 12 studies already covered by earlier IQWiG reviews; 5 of the 9 new trials involved NPWT systems that are not on the market. The researchers found that the frequency of complete wound closure was stated in only five of the nine new reports, and a statistically significant effect in favor of NPWT was found in only two trials. The results of eight of the nine new trials were hard to interpret, both because of apparent bias and because diverse types of wounds were treated. The researchers concluded that although there may be a positive effect of NPWT, there was no clear evidence that wounds heal any better or worse with NPWT than with conventional treatment. The study was published in the June 3, 2011, edition of Deutsches Ärzteblatt International.

"The available pool of only 21 RCTs remains too small to provide a clear answer to the question of whether or not NPWT is superior to conventional wound treatment," said lead author Frank Peinemann, MD, MSc. "The difficulty of interpreting the RCTs is caused essentially by the heterogeneity of the various indications for NPWT on the one hand, and the considerable qualitative and quantitative shortcomings of the trials on the other."

NPWT is a therapeutic technique used to promote healing in acute or chronic wounds and enhance healing of first- and second-degree burns, by controlled application of subatmospheric pressure to the local wound environment using a sealed wound dressing connected to a vacuum pump. The use of this technique in wound management increased dramatically over the 1990s and 2000s. Research on the effectiveness of NPWT is generally flawed and methodologically poor quality, but does support the use of the technique for diabetic ulcers.

Related Links:

Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen



Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Semi‑Automatic Defibrillator
Heart Save AED (ED300)
VTE Prevention System
Flowtron ACS900
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.